538 related articles for article (PubMed ID: 3543649)
1. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
Lyon RA; Davis KH; Titeler M
Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
[TBL] [Abstract][Full Text] [Related]
2. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
Branchek T; Adham N; Macchi M; Kao HT; Hartig PR
Mol Pharmacol; 1990 Nov; 38(5):604-9. PubMed ID: 2233697
[TBL] [Abstract][Full Text] [Related]
3. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
Peroutka SJ; Hamik A; Harrington MA; Hoffman AJ; Mathis CA; Pierce PA; Wang SS
Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
5. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
6. High affinity agonist binding to cloned 5-hydroxytryptamine2 receptors is not sensitive to GTP analogs.
Szele FG; Pritchett DB
Mol Pharmacol; 1993 Jun; 43(6):915-20. PubMed ID: 8316223
[TBL] [Abstract][Full Text] [Related]
7. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
8. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
[TBL] [Abstract][Full Text] [Related]
9. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
10. Serotonin 5-HT1D receptors in human prefrontal cortex and caudate: interaction with a GTP binding protein.
Herrick-Davis K; Titeler M; Leonhardt S; Struble R; Price D
J Neurochem; 1988 Dec; 51(6):1906-12. PubMed ID: 3141589
[TBL] [Abstract][Full Text] [Related]
11. [3H]ketanserin labels serotonin 5-HT2 and alpha 1-adrenergic receptors in human brain cortex.
Hoyer D; Vos P; Closse A; Palacios JM; Engel G; Davies H
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S48-50. PubMed ID: 2446070
[TBL] [Abstract][Full Text] [Related]
12. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
13. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.
Battaglia G; Shannon M; Titeler M
J Neurochem; 1984 Nov; 43(5):1213-9. PubMed ID: 6491656
[TBL] [Abstract][Full Text] [Related]
14. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
[TBL] [Abstract][Full Text] [Related]
15. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
Harden TK; Meeker RB; Martin MW
J Pharmacol Exp Ther; 1983 Dec; 227(3):570-7. PubMed ID: 6317839
[TBL] [Abstract][Full Text] [Related]
16. Evidence for distinct 5-hydroxytryptamine2 binding site subtypes in cortical membrane preparations.
Pierce PA; Peroutka SJ
J Neurochem; 1989 Feb; 52(2):656-8. PubMed ID: 2911036
[TBL] [Abstract][Full Text] [Related]
17. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
[TBL] [Abstract][Full Text] [Related]
18. Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Sleight AJ; Stam NJ; Mutel V; Vanderheyden PM
Biochem Pharmacol; 1996 Jan; 51(1):71-6. PubMed ID: 8534270
[TBL] [Abstract][Full Text] [Related]
19. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
Pranzatelli MR; Murthy JN; Pluchino RS
J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
[TBL] [Abstract][Full Text] [Related]
20. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
Martin MW; Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
